UpToDate

According to an Outsell analyst report, trust is now a core purchasing requirement for AI in healthcare. See how leading organizations are treating AI trust as a governance priority: ow.ly/mfj550ZmtWH

As digital health continues to evolve, the organizations that succeed will not be those with the most advanced AI — but those that develop trust and empower AI-literate users. Learn why: ow.ly/67AE50ZiUih

🧠 It's Clinical Challenge Time! Today's question is from the Pulmonary and Critical Care Medicine specialty. When used for patients with acute hypoxemic respiratory failure, high-flow oxygen delivered via nasal cannulae (HFNC) is associated with all of the following EXCEPT: A. Improved mortality B. Reduced reintubation C. Improved dyspnea D. Improved carbon dioxide levels Reply with your answer 👇

A trial finds mavacamten improves LVOT gradient and NYHA functional class in symptomatic adolescents with hypertrophic cardiomyopathy but not shortness of breath. Stay #UpToDate with What’s New in #Pediatrics: ow.ly/1EM450Zhocf  #ClinicalUpdates #MedTwitter

Health Canada is reviewing significant concerns regarding the data integrity of the ADVOCATE trial, which served as the primary efficacy study supporting the authorization of Tavneos (avacopan). 💊ow.ly/Ypt950ZlFEY 💊ow.ly/tvp650ZlFEZ

No matter the practice environment, #UpToDate supports confident, quality care. Hear from a loyal user how UpToDate empowers clinicians on missions, in the field, and in the hospital. Learn more: ow.ly/rvaR50ZlIZf

AI needs to be able to admit “I don’t know" Sheila Bond, MD, Director, Clinical Content Strategy, Clinical Effectiveness, Wolters Kluwer Health explains why trust in clinical AI at the point of care takes more than strong benchmark scores. Honesty matters, especially in clinical AI. Read the white paper: ow.ly/EGRw50Z6FG9 #ClinicalAI #HealthIT #ClinicalDecisionSupport

Clinicians benefit from video-educated patients. When patients receive access to evidence-based videos that meet them at their level, clinicians can experience reduced burden, fewer interruptions, and less burnout. Learn more: ow.ly/bT7J50Zl4P8

As the demands on medical library services continue to evolve, supporting fast access to trusted clinical evidence remains at the core of what you do. That’s why we’re delighted to be the Symposium Sponsor at ICML 2026 in Glasgow. At this year’s conference, we’ll be focusing on how UpToDate, enhanced with UpToDate Expert AI, is helping medical librarians support clinicians with even greater speed and confidence. Join us on 15 July for a live, interactive demo: We’ll put UpToDate Expert AI to the test using your questions, showing how it builds on the trusted content foundation to deliver rapid, evidence-based insights. We’d love to connect and hear how your services are evolving - and where we can support you. Learn about UpToDate Expert AI and request a meeting with the team: ow.ly/VAYJ50ZlzUm #ICML2026 #MedicalLibrarians #EvidenceBasedMedicine #UpToDate #AIinHealthcare

Can AI alone solve healthcare's toughest challenges? Not without human clinical expertise. True clinical intelligence needs both expert and machine. Read the full report to learn why: ow.ly/mRZv50Zesxl #ClinicalAI #HealthTech

In adults new to smartphones, use at night delayed sleep onset and shortened sleep through changes in circadian physiology and behavior changes, including delaying bedtime. tay #UpToDate with What’s New in #SleepMedicine: ow.ly/Sqfe50Zho9E  #ClinicalUpdates #MedTwitter

The FDA has extended the expiration date of antivenin (Micrurus fulvius) (equine origin) lot CL6814 from June 30, 2026, to December 31, 2026. The extension is based on FDA evaluation of stability data. Lot CL6814 is labeled with an expiration date of 06/2022, which was assigned at the time of manufacture. Check out our drug referential resources: 💊ow.ly/OFOL50Zl4La 💊ow.ly/t0lF50Zl4Lb #DrugNews #Pharmacy #Medication

🧠 It's Clinical Challenge time! Which of the following direct oral anticoagulants (DOACs) is associated with the lowest bleeding risk when used for the treatment of venous thromboembolism (VTE)? A. Apixaban B. Rivaroxaban Reply with your answer👇

Patients want to be empowered members of their own care teams. Embedded video enables them with the same evidence-based guidance that clinicians already trust—in a format that meets them where they are. Learn more: ow.ly/YLyU50Zhnrs

New trial in >1400 participants receiving subcutaneous semaglutide for weight loss shows greater efficacy with 7.2 mg versus 2.4 mg dose. Stay #UpToDate with What’s New in #PrimaryCare: ow.ly/WlKQ50ZhnGW  #ClinicalUpdates #MedTwitter

The @US_FDA has approved an expanded indication for AbbVie’s Skyrizi (risankizumab-rzaa) subcutaneous or intravenous injection to include the treatment of pediatric patients 6 years and older with active psoriatic arthritis. Skyrizi was previously approved for this indication in adults only. Check out our drug referential resources: 💊ow.ly/vAIm50ZiM7r 💊ow.ly/mVvA50ZiM7t #DrugNews #Pharmacy #Medication

40% of healthcare staff report seeing unauthorized AI tools used at work. Learn the risks and how to strengthen your AI-enabled medication platform for appropriate, system-wide use. ow.ly/kTgH50Z4YeA

Joint statement from the AHA and other leading cardiology societies notes rising prevalence of CV disease; calls for policies and regulations to decrease environmental exposures. Stay #UpToDate with What’s New in #PrimaryCare: ow.ly/Gxfb50ZhnBJ  #ClinicalUpdates #MedTwitter

It was great connecting with clinicians, pharmacists, and healthcare leaders at the Korean Society of Medical Informatics (KOSMI) 2026 Spring Conference from 25-26 June. The conversations throughout the event reinforced a shared focus on advancing medication safety and strengthening clinical decision support at the point of care. Medi-Span was pleased to be there alongside ONES Global, engaging with stakeholders on how trusted, structured drug data can enhance medication safety and support more informed, confident clinical decision-making at the point of care in Korea. We appreciate the thoughtful discussions and look forward to continuing to build on these exchanges in the months ahead.

Healthcare AI shapes care decisions. Digital health tech can drive AI literacy to help users interpret AI outputs responsibly. Read more: ow.ly/i8pT50ZhMfe